Horm Metab Res 2011; 43(13): 970-976
DOI: 10.1055/s-0031-1291273
Humans, Clinical
© Georg Thieme Verlag KG Stuttgart · New York

Further Studies on Delineating Thyroid-Stimulating Hormone (TSH) Reference Range

M. Žarković
1   School of Medicine, University of Belgrade, Belgrade, Serbia
2   Clinic of Endocrinology, Clinical Center of Serbia, Belgrade, Serbia
,
J. Ćirić
1   School of Medicine, University of Belgrade, Belgrade, Serbia
2   Clinic of Endocrinology, Clinical Center of Serbia, Belgrade, Serbia
,
B. Beleslin
1   School of Medicine, University of Belgrade, Belgrade, Serbia
2   Clinic of Endocrinology, Clinical Center of Serbia, Belgrade, Serbia
,
S. Ćirić
2   Clinic of Endocrinology, Clinical Center of Serbia, Belgrade, Serbia
,
P. Bulat
1   School of Medicine, University of Belgrade, Belgrade, Serbia
3   Serbian Institute of Occupational Health, Belgrade, Serbia
,
D. Topalov
4   Institute for Laboratory Diagnostics “Konzilijum”, Belgrade, Serbia
,
B. Trbojević
1   School of Medicine, University of Belgrade, Belgrade, Serbia
2   Clinic of Endocrinology, Clinical Center of Serbia, Belgrade, Serbia
,
Serbian Thyroid Study Group › Author Affiliations
Further Information

Publication History

received 23 May 2011

accepted 28 September 2011

Publication Date:
08 November 2011 (online)

Abstract

The aim of the study was to evaluate thyroid-stimulating hormone (TSH) concentration in a reference group and to compare it with the TSH in subjects with high probability of thyroid dysfunction. The study population consisted of 852 subjects. The reference group consisting of 316 subjects was obtained by the exclusion of the subjects having thyroid disease, taking thyroid influencing drugs, having increased thyroid peroxidase (TPO) antibodies, or having abnormal thyroid ultrasound. 42 high probability of thyroid dysfunction subjects were defined by the association of increased TPO antibody concentration, changed echogenicity, and changed echosonographic structure of thyroid parenchyma. In the reference group TSH reference range was 0.45 mU/l (95% CI 0.39–0.56 mU/l) to 3.43 mU/l (95% CI 3.10–4.22 mU/l). To distinguish reference and high probability of thyroid dysfunction group a TSH threshold was calculated. At a threshold value of 3.09 mU/l (95% CI 2.93–3.38 mU/l), specificity was 95% and sensitivity 38.1%. Using 2 different approaches to find upper limit of the TSH reference range we obtained similar results. Using reference group only a value of 3.43 mU/l was obtained. Using both reference group and subjects with the high probability of thyroid dysfunction we obtained 95% CI for the upper reference limit between 2.93 and 3.38 mU/l. Based on these premises, it could be argued that conservative estimate of the TSH upper reference range should be 3.4 mU/l for both sexes.

*

*  Members of the Serbian Thyroid Study Group: Novi Sad: L. T. Djilas, B. Kovačev, M. Medić; Niš: M. Pešić, D. Dimić, S. Radenković; Pirot: F. Pejčić; Kragujevac: A. Đukić, D. Bubanja, V. Mladenović; Gornji Milanovac: J. Miljević.


 
  • References

  • 1 Spencer CA, Hollowell JG, Kazarosyan M, Braverman LE. National Health and Nutrition Examination Survey III thyroid-stimulating hormone (TSH)-thyroperoxidase antibody relationships demonstrate that TSH upper reference limits may be skewed by occult thyroid dysfunction. J Clin Endocrinol Metab 2007; 92: 4236-4240
  • 2 Surks MI, Goswami G, Daniels GH. The thyrotropin reference range should remain unchanged. J Clin Endocrinol Metab 2005; 90: 5489-5496
  • 3 Wartofsky L, Dickey RA. The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab 2005; 90: 5483-5488
  • 4 Laurberg P, Andersen S, Carle A, Karmisholt J, Knudsen N, Pedersen IB. The TSH upper reference limit: where are we at?. Nat Rev Endocrinol 2011; 7: 232-239
  • 5 Baskin HJ, Cobin RH, Duick DS, Gharib H, Guttler RB, Kaplan MM, Segal RL. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 2002; 8: 457-469
  • 6 Boucai L, Surks MI. Reference limits of serum TSH and free T4 are significantly influenced by race and age in an urban outpatient medical practice. Clin Endocrinol (Oxf) 2009; 70: 788-793
  • 7 Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, LiVosli VA, Niccoli-Sire P, John R, Ruf J, Smyth PP, Spencer CA, Stockigt JR. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003; 13: 3-126
  • 8 Surks MI, Boucai L. Age- and Race-Based Serum Thyrotropin Reference Limits. J Clin Endocrinol Metab 2010; 95: 496-502
  • 9 R Development Core Team . R: A Language and Environment for Statistical Computing. In. Vienna, Austria: R Foundation for Statistical Computing; 2010
  • 10 Venables WN, Ripley BD. Univariate statistics. In: Venables WN, Ripley BD. (eds.) Modern applied statistics with S. New York: Springer; 2002: 107-138
  • 11 Wand M, Ripley BD. KernSmooth: Functions for kernel smoothing for Wand & Jones (1995). Last assessed 09.05.2011. Available from http://CRAN.R-project.org/package=KernSmooth
  • 12 Neave HR, Worthington PL. Distribution free tests. London: Unwin Hyman; 1988
  • 13 Sekhon JS. Multivariate and Propensity Score Matching Software with Automated Balance Optimization: The Matching package for R. J Stat Softw 2011; 42: 1-52
  • 14 Stephens MA. EDF Statistics for Goodness of Fit and Some Comparisons. J Am Stat Assoc 1974; 69: 730-737
  • 15 Good PI. Resampling Methods: A Practical Guide to Data Analysis. Boston: Birkhäuser; 2006
  • 16 Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanches JC, Muller M. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 2011; 12: 77-84
  • 17 Altman DG. Practical statistics for medical research. Boca Raton: Chapman & Hall/CRC; 1991
  • 18 Guan H, Shan Z, Teng X, Li Y, Teng D, Jin Y, Yu X, Fan C, Chong W, Yang F, Dai H, Yu Y, Li J, Chen Y, Zhao D, Shi X, Hu F, Mao J, Gu X, Yang R, Chen W, Tong Y, Wang W, Gao T, Li C, Teng W. Influence of iodine on the reference interval of TSH and the optimal interval of TSH: results of a follow-up study in areas with different iodine intakes. Clin Endocrinol (Oxf) 2008; 69: 136-141
  • 19 Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87: 489-499
  • 20 Hamilton TE, Davis S, Onstad L, Kopecky KJ. Thyrotropin levels in a population with no clinical, autoantibody, or ultrasonographic evidence of thyroid disease: implications for the diagnosis of subclinical hypothyroidism. J Clin Endocrinol Metab 2008; 93: 1224-1230
  • 21 Kratzsch J, Fiedler GM, Leichtle A, Brugel M, Buchbinder S, Otto L, Sabri O, Matthes G, Thiery J. New reference intervals for thyrotropin and thyroid hormones based on National Academy of Clinical Biochemistry criteria and regular ultrasonography of the thyroid. Clin Chem 2005; 51: 1480-1486
  • 22 Friis-Hansen L, Hilsted L. Reference intervals for thyreotropin and thyroid hormones for healthy adults based on the NOBIDA material and determined using a Modular E170. Clin Chem Lab Med 2008; 46: 1305-1312
  • 23 Arzideh F, Wosniok W, Haeckel R. Indirect reference intervals of plasma and serum thyrotropin (TSH) concentrations from intra-laboratory data bases from several German and Italian medical centres. Clin Chem Lab Med 2011; 49: 659-664
  • 24 Katayev A, Balciza C, Seccombe DW. Establishing reference intervals for clinical laboratory test results: is there a better way?. Am J Clin Pathol 2010; 133: 180-186
  • 25 Estaquio C, Valeix P, Leenhardt L, Modigliani E, Boutron-Ruault MC, Cherie-Challine L, Legrand M, Hercberg S, Castetbon K. Serum thyrotropin and free thyroxine reference ranges as defined in a disease-free sample of French middle-aged adults. Clin Chem Lab Med 2009; 47: 1497-1505
  • 26 Rosario PW, Xavier AC, Calsolari MR. TSH reference values for adult Brazilian population. Arq Bras Endocrinol Metabol 2010; 54: 603-606
  • 27 Volzke H, Alte D, Kohlmann T, Ludemann J, Nauck M, John U, Meng W. Reference intervals of serum thyroid function tests in a previously iodine-deficient area. Thyroid 2005; 15: 279-285
  • 28 Volzke H, Schmidt CO, John U, Wallaschofski H, Dorr M, Nauck M. Reference levels for serum thyroid function tests of diagnostic and prognostic significance. Horm Metab Res 2010; 42: 809-814
  • 29 Vejbjerg P, Knudsen N, Perrild H, Laurberg P, Carle A, Pedersen IB, Rasmussen LB, Ovesen L, Jorgensen T. Lower prevalence of mild hyperthyroidism related to a higher iodine intake in the population: prospective study of a mandatory iodization programme. Clin Endocrinol (Oxf) 2009; 71: 440-445
  • 30 The International Council for the Control of Iodine Deficiency Disorders . Summary of Iodine Nutrition in Western & Central Europe. Last assessed 09.05.2011. Available from: http://www.iccidd.org/pages/protecting-children/global-efforts/western-central-europe.php
  • 31 Andersen S, Pedersen KM, Bruun NH, Laurberg P. Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab 2002; 87: 1068-1072